• STJ71141 (0. 03µg/ml) staining of Human Pancreas lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.

Anti-PDIA2/PDIP antibody (Internal) (STJ71141)

SKU:
STJ71141-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB/IHC
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-PDIA2/PDIP (Internal) is suitable for use in ELISA, Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: WB-0.01-0.03µg/ml
IHC-3.75µg/ml
ELISA-antibody detection limit dilution 1:64000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: PDIA2
Gene ID: 64714
Uniprot ID: PDIA2_HUMAN
Immunogen Region: Internal
Accession Number: NP_006840.2
Immunogen Sequence: NLETTKKYAPVD
Post Translational Modifications The disulfide-linked homodimer exhibits an enhanced chaperone activity. Glycosylated.
Function Acts as an intracellular estrogen-binding protein. May be involved in modulating cellular levels and biological functions of estrogens in the pancreas. May act as a chaperone that inhibits aggregation of misfolded proteins.
Protein Name Protein Disulfide-Isomerase A2
Pancreas-Specific Protein Disulfide Isomerase
Pdip
Cellular Localisation Endoplasmic Reticulum Lumen
Alternative Antibody Names Anti-Protein Disulfide-Isomerase A2 antibody
Anti-Pancreas-Specific Protein Disulfide Isomerase antibody
Anti-Pdip antibody
Anti-PDIA2 antibody
Anti-PDIP antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance